Table 2.
The comparisons of cytokine levels between two groups.
| Cytokines | Primary CRSwNP (n = 36) | Recurrent CRSwNP (n = 36) | P value |
|---|---|---|---|
| CTACK | 1002.9 ± 311.3 | 1047.1 ± 380.6 | 0.591 |
| Eotaxin | 35.8 ± 15.2 | 50.7 ± 27.2 | 0.005 |
| G-CSF | 86.8 ± 52.6 | 127.9 ± 74.6 | 0.009 |
| GM-CSF | 1.0 ± 0.7 | 1.1 ± 0.8 | 0.296 |
| IFN-α | 0.7 ± 1.4 | 1.9 ± 2.1 | 0.010 |
| IFN-γ | 6.4 ± 3.3 | 5.3 ± 2.4 | 0.092 |
| IL-10 | 3.0 ± 4.4 | 2.7 ± 5.5 | 0.791 |
| IL-13 | 1.7 ± 0.8 | 2.2 ± 1.0 | 0.039 |
| IL-15 | 37.8 ± 16.8 | 37.5 ± 20.5 | 0.950 |
| IL-16 | 104.8 ± 62.9 | 123.8 ± 63.8 | 0.207 |
| IL-17A | 6.7 ± 5.9 | 9.3 ± 4.5 | 0.042 |
| IL-18 | 34.1 ± 23.7 | 36.6 ± 17.8 | 0.612 |
| IL-1α | 10.1 ± 7.3 | 10.8 ± 5.9 | 0.665 |
| IL-1β | 2.2 ± 1.4 | 2.6 ± 0.9 | 0.097 |
| IL-2 | 0.5 ± 0.3 | 0.6 ± 0.3 | 0.489 |
| IL-25 | 482.0 ± 580.6 | 480.9 ± 363.3 | 0.992 |
| IL-3 | 11.2 ± 18.7 | 11.6 ± 8.6 | 0.918 |
| IL-33 | 222.5 ± 23.6 | 221.0 ± 23.3 | 0.778 |
| IL-4 | 1.9 ± 0.5 | 1.9 ± 0.6 | 0.630 |
| IL-5 | 2.4 ± 2.3 | 2.6 ± 2.7 | 0.718 |
| IL-6 | 1.0 ± 0.9 | 0.6 ± 0.5 | 0.005 |
| IL-7 | 5.6 ± 5.4 | 6.2 ± 5.6 | 0.616 |
| IL-8 | 105.1 ± 72.5 | 96.3 ± 64.1 | 0.589 |
| IL-9 | 233.4 ± 22.4 | 236.4 ± 25.2 | 0.603 |
| MCP-1 | 36.2 ± 26.6 | 51.8 ± 36.9 | 0.044 |
| MCP-3 | 1.6 ± 1.9 | 2.1 ± 2.6 | 0.345 |
| RANTES | 5902.4 ± 1400.5 | 6518.6 ± 1571.1 | 0.038 |
| TNF-α | 18.4 ± 6.1 | 18.5 ± 7.3 | 0.928 |
| TNF-β | 74.9 ± 20.4 | 76.8 ± 24.4 | 0.717 |
| TSLP | 841.9 ± 394.1 | 957.4 ± 354.8 | 0.196 |
CRSwNP: chronic rhinosinusitis with nasal polyps; CTACK: cutaneous T cell attracting chemokine; G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; IFN: interferon alpha; IL: interleukin; MCP: monocyte chemotactic protein; RANTES: regulated upon activation normally T expressed and presumably secreted; TNF: tumour necrosis factor-alpha; TSLP: thymic stromal lymphopoietin.